JP2025539807A5 - - Google Patents
Info
- Publication number
- JP2025539807A5 JP2025539807A5 JP2025528843A JP2025528843A JP2025539807A5 JP 2025539807 A5 JP2025539807 A5 JP 2025539807A5 JP 2025528843 A JP2025528843 A JP 2025528843A JP 2025528843 A JP2025528843 A JP 2025528843A JP 2025539807 A5 JP2025539807 A5 JP 2025539807A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- phe
- formula
- homo
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2022-0155122 | 2022-11-18 | ||
| KR20220155122 | 2022-11-18 | ||
| PCT/KR2023/018574 WO2024107014A1 (en) | 2022-11-18 | 2023-11-17 | Anti-basal cell adhesion molecule antibody-drug conjugate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025539807A JP2025539807A (ja) | 2025-12-09 |
| JP2025539807A5 true JP2025539807A5 (enExample) | 2026-01-27 |
Family
ID=91085056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025528843A Pending JP2025539807A (ja) | 2022-11-18 | 2023-11-17 | 抗基底細胞接着分子抗体－薬物コンジュゲート |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20260191982A1 (enExample) |
| EP (1) | EP4619046A1 (enExample) |
| JP (1) | JP2025539807A (enExample) |
| KR (1) | KR20250108120A (enExample) |
| CN (1) | CN120417938A (enExample) |
| AU (1) | AU2023381368A1 (enExample) |
| CL (1) | CL2025001431A1 (enExample) |
| IL (1) | IL320899A (enExample) |
| MX (1) | MX2025005787A (enExample) |
| TW (1) | TW202430222A (enExample) |
| WO (1) | WO2024107014A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250164033A (ko) * | 2024-05-14 | 2025-11-24 | 주식회사 지놈앤컴퍼니 | 항-bcam 항체 및 이의 컨쥬게이트 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015292744C1 (en) * | 2014-07-21 | 2021-01-21 | Novartis Ag | Treatment of cancer using humanized anti-BCMA chimeric antigen receptor |
| CA3082271A1 (en) * | 2017-11-14 | 2019-05-23 | Debiopharm Research & Manufacturing S.A. | Ligand-drug-conjugates as substrates for selective cleavage by the exopeptidase activity of cathepsin b |
| TWI924779B (zh) * | 2021-02-04 | 2026-05-11 | 大陸商上海森輝醫藥有限公司 | 糖皮質激素受體激動劑的藥物偶聯物及其在醫藥上的應用 |
-
2023
- 2023-11-17 AU AU2023381368A patent/AU2023381368A1/en active Pending
- 2023-11-17 JP JP2025528843A patent/JP2025539807A/ja active Pending
- 2023-11-17 CN CN202380089128.7A patent/CN120417938A/zh active Pending
- 2023-11-17 EP EP23892076.3A patent/EP4619046A1/en active Pending
- 2023-11-17 KR KR1020257020363A patent/KR20250108120A/ko active Pending
- 2023-11-17 IL IL320899A patent/IL320899A/en unknown
- 2023-11-17 TW TW112144641A patent/TW202430222A/zh unknown
- 2023-11-17 WO PCT/KR2023/018574 patent/WO2024107014A1/en not_active Ceased
- 2023-11-17 US US19/130,894 patent/US20260191982A1/en active Pending
-
2025
- 2025-05-15 CL CL2025001431A patent/CL2025001431A1/es unknown
- 2025-05-16 MX MX2025005787A patent/MX2025005787A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7254861B2 (ja) | エリブリンをベースとする抗体－薬物コンジュゲート及び使用方法 | |
| US20240409628A1 (en) | Antibody, antibody-drug conjugate thereof and use thereof | |
| US20230173093A1 (en) | Charge variant linkers | |
| Senter | Potent antibody drug conjugates for cancer therapy | |
| AU2015210578B2 (en) | Ligand-cytotoxic drug conjugate, preparation method therefor, and uses thereof | |
| JP2018520991A5 (enExample) | ||
| JP2022530524A5 (enExample) | ||
| CN113766954A (zh) | 喜树碱衍生物 | |
| RU2019129839A (ru) | Производные майтанзиноида с саморасщепляющимися пептидными линкерами и их конъюгаты | |
| JP2018520092A5 (enExample) | ||
| CN110240654A (zh) | 结合cd73的抗体-药物偶联物 | |
| JP2017522871A5 (enExample) | ||
| FI3930847T3 (fi) | Korkea-affiinisia anti-MERTK-vasta-aineita ja niiden käyttöjä | |
| HRP20220172T1 (hr) | Protutijela protiv cd71 koja se mogu aktivirati, te postupci njihove uporabe | |
| CN105979971A (zh) | 抗体-药物缀合物和免疫毒素 | |
| KR20160113623A (ko) | 항체-약물 접합체 및 면역독소 | |
| RU2002125514A (ru) | SCFV против EGFRVIII с улучшенной цитотоксичностью и выходом, иммунотоксины на их основе, и способы их применения | |
| TW201925229A (zh) | 經捲曲螺旋遮蔽之二價抗體 | |
| TWI845724B (zh) | 用於偶聯的多肽複合物及其應用 | |
| JP2020526584A5 (enExample) | ||
| JP2023159335A (ja) | コンジュゲート化のためのシステイン突然変異抗体 | |
| JP2019524640A5 (enExample) | ||
| JP2024545170A5 (enExample) | ||
| CN110575548A (zh) | 靶向于cd73的抗体-药物偶联物及其制法和用途 | |
| JP2023506158A5 (enExample) |